References
- Alberti, K.G., Zimmet, P, Shaw. J. (2005). The metabolic syndrome - anew worldwide definition. Lancet, 366, 1059-1062.
- Bays, H.E. (2009). „Sick fat" metabolic disease, and atherosclerosis. Amer. J. Med., 122, S26-S37.
- Brenta, G. (2011). A view of Diabetes from thyroid corner. Thyroid Int., 3, 3-15.
- Bruce, K.D., Byrne, C.D. (2009). The metabolic syndrome: Common origins of a multifactoral disorder. Postrad Med. J., 85, 614-621.
- Chiarelli, F., Marcovecchio, M.L. (2008). Insulin resistance and obesity in childhood. Eur. J. Endocrin., 159, 67-74.
- De Gonzalez, A.B., Hartge, P., Cerhan, J.R., Flint, A.J., Hannan, L., MacInnis, R.J., Moore, S.C., Tobias, G.S., Anton-Culver, H., Beane Freeman, L.W., Beeson. L,, Clipp, S.L., English, D.R., Folsom, A.R., Freed- man, D.M., Giles, G., Hakansson, N., Henderson, K.D., Hoffman-Bolton, J., Hoppin, J.A., Koenig, K.L., Lee, I.M., Linet, M.S., Park, Y., Pocobelli, G., Schatzkin, A., Sesso, H.D., Weiderpass, E., Willcox, B.J., Wolk, A., Zeleniuch-Jacquotte, A., Willett, W.C., Thun, M.J. (2010). Body-Mass index and mortality among 1.46 million white adults. New Eng. J. Med., 363, 2211-2219.
- De Fronzo, R.A., Ferrannini, E. (1991). Insulin resistance. A multifactoral syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14, 173-194.
- Despres, J.-P., Brewer, H.B. (2008). Metabolic syndrome: The dysmetabolic state of dysfunctional adipose tissue and insulin resistance. Eur. Heart J., 10(Suppl. B), B1-B3.
- Ekelund, U., Anderssen, S., Anderssen, L.B., Riddoch, C.J., Sardinha, L.B., Jian'an Luan, Froberg, K., Brage, S. (2009). Prevalence and correlates of the metabolic syndrome in a population-based sample of European youth. Amer. J. Clin. Nutr., 89, 90-96.
- Ferrannini, E., Sironi A.M., Iozzo, P., Gastaldelli, A. (2008). Intra-abdomi- nal adiposity, abdominal obesity, and cardiometabolic risk. Eur. Heart J., 10(Suppl. B), B4-B11.
- Garaulet, M., Madrid, J.A. (2009). Chronobiology, genetics and metabolic syndrome. Curr. Opinion Lipidol., 20, 127-134.
- Grundy, S.M. (2002). Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation, 105, 2696-2698.
- Grundy, S.M., Cleeman, J.I., Daniels, S.R., Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., Gordon, D.J., Krauss, R.M., Savage, P.J., Smith, S.C. Jr, Spertus, J.A., Costa, F.;American Heart Association; National Heart, Lung, and Blood Institute. (2005).Diagnosis and management of the metabolic syndrome. Circulation, 112, 2735-2752.
- Hopkins, T.A., Ouchi, N., Shibata, R., Walsh, K. (2007). Adiponectin actions in the cardiovascular system. Cardiovasc. Res., 74, 11-18.
- Hossain, B., Kawar., B, Nahas, M.E. (2007). Obesity and diabetes in the developing world - a growing challenge. New Eng. J. Med., 356(3), 213-215.
- Ibjńez, L,., Valls, C., Pota, U., Marcos, M.V., de Zegher, F. (2000). Sensiti- zation to insulin in adolescent girls to normalize hirsutism, hyperandro- genism, oligomenorrhea, dyslipidemia, and hyperinsulinemism after precocious pubarche. J. Clin. Endocrinol. Metab., 85, 3526-3530
- Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K., Tobe, K. (2006).Adiponectin and adiponectin receptors in insulin resistance, and the metabolic syndrome. J. Clin. Invest., 116, 1784-1792.
- Kaplan, N.M. (1989). The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med., 149, 1514-1520.
- Kizer, J.R., Arnold, A.M., Strotmeyer, E.S., Ives, D.G., Cushman, M., Ding, J., Kritchevsky, S.B., Chaves, P.H., Hirsch, C.H., Newman, A.B. C (2011). Change in circulating adiponectin in advanced old age: Determinants and impact on physical function and mortality. The cardiovascular health study all stars study. J. Gerontol, 66(A), 1100-1107.
- Lambert, M., O'Loughlin, J., Delvin, E.E., Levy. E., Chiolero, A., Paradis, G. (2009). Association between insulin, leptin, adiponectin and blood pressure in youth. J. Hypertens., 27(5), 1025-1032.
- Lawlor, D.A., Martin, R.M., Gunnell, D., Galobardes, B., Ebrahim, S., Sandhu, J., Ben-Shlomo, Y., McCarron, P., Davey Smith, G. (2006). Association of body mass index measured in childhood, adolescence, and young adulthood with risk of ischemic heart disease and stroke: Findings from 3 historical cohort studies. Amer. J. Clin. Nutr., 83(4), 767-773.
- Kalvelis, A., Lejnieks, A., Pirags, V., Raibarts, J. (2002). Metabolais sindroms, vadlinijas [Metabolic Syndrome: Guidelines]. Riga. 20 lpp.
- Li, S., Shin, H.J., Ding, E.L., van Dam, R.M. (2009). Adiponectin levels and disk of type 2 diabetes. JAMA, 302(2), 179-188.
- Ligere, R. (1997). Generalizetais metabolais sindroms [Generalised metabolic syndrome]. Latvijas Arsts, 2, 99-110.
- Ligere, R., Zilevica, A., Krikis, J. (2001). Vielmainas lpatnibas skoleniem [Metabolism peculiarities in schoolchildren]. Latvijas Arsts, 8, 42-47.
- Ligere, R., Madrevica, I., Krikis, J. (2002). Skolenu veseliba un vielmainas lpatnibas dazados vecumos. Qimenes Arsts, 2, 12-17.
- Madrevica, I., Ligere, R. (2002). Determinant factors of arterial hypertension in schoolage boys in Latvia. Endocrine abstracts. J. Endocrinol., 4, P39, DP9.
- Must, A., Jacques, P.F., Dallal, G.E., Bajema, C.J., Dietz, W.H. (1992). Long-term morbidity and mortality of overweight adolescents. A follow-up the Harvard Growth study of 1922 to 1935. New Engl. J. Med., 327(19), 1350-1355.
- Nishimura, R., Sano, H., Matsudaira, T., Morimoto, A., Miyashita, Y., Shirasawa, T., Kokaze, A., Tajima, N. (2009). Changes in body mass index, leptin and adiponectin in Japanese children during the three-year follow-up period: A population-based cohort study. Cardiovasc. Diabetol., 8(30), doi:10, 1186/1475-2840-8-30.
- Ogden, C.L., Carroll, M.D., Curtin, L.R., McDowell, M.A., Tabak, C.J., Flegal, K.M. (2006). Prevalence of overweight and obesity in the United States 1999-2004. JAMA, 295, 1549-1555.
- Potenza, M.V., Mechanick, J.I. (2009). The metabolic syndrome: Definition, global impact, and pathophysiology. Nutr. Clin. Pract., 24, 560-577.
- Rahmouni, K., Curtis, S. (2008). Fat factors controlling adiponectin expression. Circ. Res., 103, 565-567.
- Reaven, G.M. (1988). Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37, 1595-1607.
- Reinehr, T. (2012). Obesity and thyroid function. Endocr. Abstr., 29, S59.1.
- Steinberger, J., Daniels, S.R., Eckel, R.H., Hayman, L., Lustig, R.H., McCrindle, B., Mietus-Snyder. M.L. (2009). Progress and challenges in metabolic syndrome in children and adolescents. Circulation, 119, 628-647.
- Stocks, T., Rapp, K., Bjorge, T., Manjer, J., Ulmer, H., Selmer, R., Lukanova, A., Johansen, D., Concin, H., Tretli, S., Hallmans, G., Jonsson, H., Stattin, P. (2009). Blood glucose and risk of incident and fatal cancer in the Metabolic syndrome and cancer Project (Me-Can): Analysis of six prospective cohorts. PLoSMed, 6(12):e1000201.
- Terjn-Garcia, M., Bouchard, C. (2007). Genetics of the metabolic syndrome. Appl. Physiol. Nutr. Metab., 32, 89-114.
- Veldhuis, I.D., Roemmich, I.N., Richmond, E.P., Rogol, A.D., Lovejoy, J.C., Sheffield-Moore, M., Mauras, N., Bowers, C.Y. (2005). Endocrine control of body composition in infancy, childhood, and puberty. Endocr. Rev., 26, 114-146.
- Wang, J.V., Scherer, Ph.E. (2008). Adiponectin, cardiovascular function, and hypertension. Hypertension, 51, 8-14.
- Weiss, R., Otvos, J.D., Flyvbjerg, A., Miserez, A.R., Frystyk, J., Sinnreich, R., Kark, J.D. (2009). Adiponectin and lipoprotein particle size. Diabetes Care, 32(7), 1317-1319.
- Weiss, R., Dziura, I., Burgert, T.S., William, V., Tamborlane, W.V., Taksali, S.E., Yeckel, C.W., Allen, K., Lopes, M., Savoye, M., Morrison, J., Sherwin, R.S., Caprio, S. (2004). Obesity and the metabolic syndrome in children and adolescents. New Eng. J. Med., 350, 2362-2374.
- Wilson, P.W.F., Meigs, J.B. (2008). Risk of type 2 diabetes mellitus and coronary heart disease: A pivotal role for metabolic factors. Eur. Heart J. Suppl., 10(Suppl. B), B11-B15.